Drugs Information: Regadenoson
Basic Information
|
||
| ID | DDInter1575 | |
| Drug Type | small molecule | |
| Molecular Formula | C15H18N8O5 | |
| Molecular Weight | 390.360 | |
| Description | Regadenoson is a coronary vasodilator used in radionuclide myocardial perfusion imaging (MPI). | |
| ATC Classification | C01EB21 | |
| IUPAC Name | 1-{6-Amino-9-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Oxolan-2-Yl]-9H-Purin-2-Yl}-N-Methyl-1H-Pyrazole-4-Carboxamide | |
| InChI | Inchi=1S/C15H18N8O5/C1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/H2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/T7-,9-,10-,14-/M1/S1 | |
| InChI Key | LZPZPHGJDAGEJZ-AKAIJSEGSA-N | |
| Canonical SMILES | CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1 | |
| Useful Links | DrugBank ChEMBL PubChem | |
Interactions with Regadenoson
| Severity level | ID | Name | Mechanism | Detail |
|---|